X
No new patients should take Lilly’s cancer drug Lartruvo, say regulators
https://pharmaphorum.com/news/no-new-patients-should-take-lillys-cancer-drug-lartruvo-say-regulators/
soft tissue Sarcoma
Lilly’s sarcoma drug Lartruvo recommended via Cancer Drugs Fund
Lilly’s drug will be re-appraised in 2020
Lilly soft tissue cancer drug gets EU nod
Regulators conditionally back Lartruvo, based on mid-stage data.